European Journal of Surgical Oncology
Volume 33, Issue 1 , Pages 28-32 , February 2007

Local recurrence in breast carcinoma patients with T1–2 and 1–3 positive nodes: Indications for radiotherapy

,Accepted 11 October 2006.

References 

  1. Arriagada R, Rutqvist LE, Mattsson A, Kramar A, Rotstein S. Adequate locoregional treatment for early breast cancer may prevent secondary dissemination. J Clin Oncol. 1995;13:2869–2878
  2. Olivotto IA, Truong PT, Chua B. Postmastectomy radiation therapy: who needs it?. J Clin Oncol. 2004;22:4237–4239
  3. Recht A, Edge SB, Solin LJ, et al. Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol. 2001;19:1539–1569
  4. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366:2087–2106
  5. Truong PT, Berthelet E, Lee J, Kader HA, Olivotto IA. The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes. Cancer. 2005;103:2006–2014
  6. Katz A, Buchholz TA, Thames H, et al. Recursive partitioning analysis of locoregional recurrence patterns following mastectomy: implications for adjuvant irradiation. Int J Radiat Oncol Biol Phys. 2001;50:397–403
  7. In:  Greene FL,  Page DL,  Fleming ID, et al. editor. AJCC cancer staging manual. New York, NY: Springer-Verlag; 2002;
  8. Kaplan EL, Meier P. Nonparametric estimation for incomplete observations. J Am Stat Assoc. 1958;53:457–481
  9. Cox DR. Regression models and life tables. J R Stat Soc. 1972;B34:187–220
  10. Kleinbaum DG. Survival analysis. New York: Springer; 1996;p. 211–54
  11. Fernando IN. The role of radiotherapy in patients undergoing mastectomy for carcinoma of the breast. Clin Oncol. 2000;12:158–165
  12. van Tienhoven G, Voogd AC, Peterse JL, et al. Prognosis after treatment for locoregional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM). Eur J Cancer. 1999;35:32–38
  13. Ragaz J, Olivotto IA, Spinelli JJ, et al. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst. 2005;97:116–126
  14. Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high risk premenopausal women with breast cancer who receive adjuvant chemotherapy: Danish Breast Cancer Cooperative Group 82b trial. N Engl J Med. 1997;337:949–955
  15. Overgaard M, Jensen MB, Overgaard J, et al. Postoperative radiotherapy in high risk postmenopausal breast cancer patients given adjuvant tamoxifen. Danish Breast Cancer Cooperative Group 82c randomised trial. Lancet. 1999;353:1641–1648
  16. Taghian A, Jeong JH, Mamounas E, et al. Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy. Results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials. J Clin Oncol. 2004;22:4247–4254
  17. Whelan T, Levine M. More evidence that locoregional radiation therapy improves survival: what should we do?. J Natl Cancer Inst. 2005;97:82–84
  18. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;365:1687–1717
  19. Jager JJ, Volovics L, Schouten LJ, et al. Locoregional recurrences after mastectomy in breast cancer: prognostic factors and implications for postoperative irradiation. Radiother Oncol. 1999;50:267–275
  20. Fodor J, Poglar C, Major T, Nemeth G. Locoregional failure 15 years after mastectomy in women with one to three positive axillary nodes with or without irradiation. Strahlenther Onkol. 2003;179:197–202
  21. Cheng JCH, Chen CM, Liu MC, et al. Locoregional failure of postmastectomy patients with 1–3 positive axillary lymph nodes without adjuvant radiotherapy. Int J Radiat Oncol Biol Phys. 2002;52:980–988
  22. Voordeckers M, Vinh-Hung V, Van de Steen J, Lamote J, Storme G. The lymph node ratio as prognostic factor in node positive breast cancer. Radiother Oncol. 2004;70:225–230
  23. Vin-Hung V, Verschraegen C, Promish DI, et al. Ratios of involved nodes in breast cancer. Breast Cancer Res. 2004;6:R680–R688
  24. Recht A, Gray R, Davidson NE, et al. Locoregional failure ten years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology Group. J Clin Oncol. 1999;17:1689–1700
  25. Wallgren A, Bonetti M, Gelber RD, et al. Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group trials I through VII. J Clin Oncol. 2003;21:1205–1213

PII: S0748-7983(06)00408-2

doi: 10.1016/j.ejso.2006.10.022

European Journal of Surgical Oncology
Volume 33, Issue 1 , Pages 28-32 , February 2007

Article Tools